Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.

The neuroradiology journal - 1 Feb 2014

Tripathi Madhavi, Tripathi Manjari, Damle Nishikant, Kushwaha Suman, Jaimini Abhinav, D'Souza Maria M, Sharma Rajnish, Saw Sanjiv, Mondal Anupam

Abstract excerpt

Positron emission tomography (PET) imaging with F-18 fluorodeoxyglucose (FDG) can be used as a downstream marker of neuronal injury, a hallmark of neurodegenerative dementias. Characteristic patterns of regional glucose metabolism have been used to classify the dementia subtypes, namely Alzheimer's dementia (AD), frontotemporal dementia (FTD), diffuse Lewy body (DLBD) and vascular dementia (VD). We undertook this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Creutzfeldt-Jakob Syndrome
Share to Dementia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dementia, Vascular

Share to Fluorodeoxyglucose F18

Share to Frontotemporal Dementia

Share to Lewy Body Disease

Share to Positron-Emission Tomography

Share to Radiopharmaceuticals

Source

Open in PubMed Open full text

Identifiers

PMID: 24571830
DOI: 10.15274/NRJ-2014-10002
PMCID: PMC4202838

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.PMID 24571830Read ↗

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegenerationSemantic proximity Read ↗

From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias.Semantic proximity Read ↗

In vivo PET classification of tau pathologies in patients with frontotemporal dementiaSemantic proximity Read ↗

Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease.Semantic proximity Read ↗

Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical cases.Semantic proximity Read ↗

Diagnosing Alzheimer’s Disease and Discriminating Between Its Stages from Brain FDG PET Images Using a New Platform for Radiomic AnalysisSemantic proximity Read ↗

The use of an individual-based FDG-PET volume of interest approach in mild cognitive impairment: a multi-modality longitudinal follow-up studySemantic proximity Read ↗

Neuroimaging for diagnosis of dementia.Semantic proximity Read ↗

Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.Semantic proximity Read ↗

Stage-independent and stage-specific phenotypic differences between vascular dementia and Alzheimer's Disease.Semantic proximity Read ↗

Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype.Semantic proximity Read ↗

Discriminant analysis of brain imaging data identifies subjects with early Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.